Patent ID: 6696041
Filing Date: 2004-02-24
Classification: A61K,Y02A,Y10S

Abstract:
A method of reducing the risk of microbial infection and also of combating an established microbial infection which is established first in the nasal mucosa area comprising the application of a nasal spray solution within the nose, said nasal spray solution comprising an aqueous solution having;from about 0.5 ppmw to about 50,000 ppmw of sodium hypochlorite; from about 0.1 ppmw to 160,000 ppmw of a salt selected from one or more of sodium bromide and sodium iodide; from about 55 ppmw to 75,000 ppmw of sodium chloride; from about 1 ppmw to about 50,000 ppmw of iodine; from about 0.01 wt. % to about 5 wt. % of glycerin.